New Delhi, Oct. 18 -- Currently, there are no intranasal Covid-19 vaccine under clinical trial in India, clarified Union Health Minister Harsh Vardhan today.

"However, Serum Institute of India has begun manufacturing Codagenix CDX-005 which is an intranasal, live-attenuated vaccine candidate for SARS-CoV-2," Vardhan said in his sixth episode of Sunday Samvaad while interacting and responding to queries on social media.

At present, the Covid-19 vaccines closest to the finish line are designed to be injected into the arm. However, according to a recent Bloomberg report, researchers are looking at whether they can get better protection from inoculations that fight the virus at its point of attack - the nose and mouth.

An alternative to co...